Hemostemix Inc (HEM : TSX-V)
Common Stock
$0.07
CAD
+0.01 (16.67%)
Last updated: 2026-07-28
Get HEM alerts:
HEM
Hemostemix Inc
WealthAwesomePerformance
1 Day
+16.67%
1 Week
+7.69%
1 Month
+27.27%
YTD
-22.22%
Key Statistics
Market Cap
$12.30M
52W High
$0.14
52W Low
$0.04
P/E Ratio
-
50 Day MA
$0.06
200 Day MA
$0.08
Beta
0.62
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/28/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 179,822 |
| 7/27/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 21,000 |
| 7/24/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 1,000 |
| 7/23/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 19,782 |
| 7/22/2026 | $0.07 | $0.07 | $0.06 | $0.06 | $0.06 | 2,911 |
| 7/21/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 2,190 |
| 7/20/2026 | $0.06 | $0.07 | $0.06 | $0.07 | $0.07 | 31,911 |
| 7/17/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 33,911 |
| 7/16/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 34,029 |
| 7/15/2026 | $0.06 | $0.07 | $0.06 | $0.07 | $0.07 | 131,911 |
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1271.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1271.4% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
137.6%
Annualized
90-Day Vol
112.7%
Annualized
Trend (90d)
+31.1%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.05 โ C$0.12 |
| 60 trading days | C$0.08 | C$0.04 โ C$0.15 |
| 90 trading days | C$0.08 | C$0.03 โ C$0.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Hemostemix Inc
Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II clinical trial for the treatment of peripheral arterial disease, chronic limb threatening ischemia, cardiovascular ischemia and angina, and vascular dementia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-4.88M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.02
- Book Value
- -0.03
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About HEM
Market movers
Recent TSX-V movers
Top 1-day gainers โ updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| AUXX | Gold X2 Mining Inc. | $6.60 | +522.64% |
| SML | Southstone Minerals Ltd | $0.05 | +66.67% |
| LMR | Lomiko Metals Inc | $0.12 | +60.00% |
| IDL | Imaging Dynamics Company Ltd | $0.07 | +50.00% |
| GEL | Tangelo Games Corp | $0.14 | +33.33% |
| MCF | Pinedale Energy Limited | $0.02 | +33.33% |
| MSC | Millennium Silver Corp | $0.02 | +33.33% |
| PLO-H | Paloma Resources Inc | $0.02 | +33.33% |
HEM.V news timeline
7 articles covering HEM.V, most recent first
Latest